Schrodinger, Inc..
SDGR.US | Research and experimental development on natural sciences and engineering
Schrödinger, Inc. is a technology company focused on revolutionizing drug discovery and materials science through the use of computational chemistry. They develop and market software solutions that enable pharmaceutical, biotechnology, and materials science companies to accelerate their research and...Show More
Better Health for All
0
Insufficient evidence to determine a value score for Schrodinger, Inc. regarding Better Health for All. No articles or relevant information found. A neutral score of 0 is assigned.
Materiality Analysis: Company Summary (75-100 words): Schrödinger, Inc. operates in the life sciences and materials science industries, providing a computational platform for molecular discovery. It has two segments: Software, which sells its platform, and Drug Discovery, which focuses on developing preclinical and clinical programs, both internally and through collaborations. A key partnership is with Novartis Pharma AG. The company's core business involves enabling and conducting drug discovery through computational methods.
Peer Comparison (50-75 words): Compared to peers in computational drug discovery, Schrödinger is fairly standard in its potential impact on "Better Health for All." Its software tools can accelerate drug development, but the actual health impact depends on how its clients and partners utilize the platform. The Novartis collaboration is a positive signal.
Materiality Assessment (1-2 clear sentences): Schrödinger's business model is fundamentally supportive of the "Better Health for All" value, with medium materiality, as its technology directly contributes to the efficiency and effectiveness of drug discovery processes. However, the ultimate impact depends on the downstream applications and accessibility of the drugs developed using its platform.
Detailed Rationale (150-200 words): Schrödinger's software and drug discovery efforts have the potential to significantly accelerate the development of new treatments and therapies. By improving the efficiency of molecular discovery, the company can indirectly contribute to better health outcomes. The collaboration with Novartis suggests a commitment to translating research into tangible medical advancements. However, the company's direct impact on accessibility and affordability of these potential drugs is limited. The materiality is medium because while the potential for positive impact is significant, it is contingent on the actions of its partners and customers, as well as broader market forces that determine drug pricing and distribution. The company's internal drug discovery programs offer more direct control over accessibility, but these are still in early stages.
Value Interaction Notes (if applicable, 25-50 words): The pursuit of novel drug molecules may involve trade-offs between efficacy, safety, and cost, potentially creating tensions with other values if accessibility is compromised for profitability.
Scoring Boundary Flags (if applicable, 25-50 words): Scores in the highest range should be avoided unless there is clear evidence of Schrödinger actively promoting access to affordable medicines developed using its platform, especially in low-income countries. A score above 7 is unlikely without strong evidence.
Fair Money & Economic Opportunity
0
Schrödinger, Inc. is a technology company focused on drug discovery and materials science, not a financial institution.
1
As such, the company does not offer lending, deposit, or other consumer financial services.
2
Therefore, all KPIs related to financial products, fees, lending practices, debt burden, and financial literacy initiatives for consumers are not applicable to its core business model. The company does not have an APR or fee structures to evaluate, nor does it generate revenue from high-cost financial products.
3
It does not have a loan or insurance book, nor does it manage customer finance data or provide debt products to consumers.
4
While Schrödinger engages in philanthropic collaborations to benefit underserved populations and offers its software at discounts to academic institutions and non-profits, these activities do not align with the specific financial service definitions of the rubric's KPIs.
5
Fair Pay & Worker Respect
20
Schrödinger, Inc. reported a CEO pay ratio of 26:1 in 2024, with the CEO's total compensation at $4,407,100 and median employee pay at $171,183.
1
Employee engagement is strong, with a 4.4 out of 5-star rating (88%) on Glassdoor based on 133 reviews, and 78% of employees stating they would recommend working at the company.
2
The company has not had any regulatory actions, violations, fines, or compliance issues related to labor practices, including modern slavery or human trafficking, in the past two years.
3
Fair Trade & Ethical Sourcing
-30
Schrödinger, Inc. is a technology company focused on drug discovery software and does not procure or trade physical commodities, making fair-trade certification not applicable.
1
The company finalized a Supplier Code of Conduct at the end of 2023, which will be rolled out in 2024.
2
It also adopted a Global Human Rights Policy, which applies to suppliers and states that non-compliance may lead to contract termination.
3
However, there is no evidence stating the percentage of supplier contracts that currently include enforceable ethical-sourcing clauses.
Honest & Fair Business
-20
The company has a formal whistleblower policy that explicitly prohibits retaliation against whistleblowers acting in good faith.
1
It outlines internal and external channels for anonymous reporting, including external providers like Lighthouse and Ombuds Office, and covers suspected accounting and auditing concerns.
2
The company had one financial restatement in 2022 related to drug discovery revenue.
3
Its consolidated financial statements are audited by KPMG LLP.
4
The company states compliance with anti-corruption laws such as the FCPA and UK Bribery Act, and mentions implementing anti-bribery training, but lacks details on the frequency or effectiveness metrics of this training.
5
External audit opinions by KPMG LLP and compliance with cGMP and GCP regulations provide some independent verification of ethical claims and compliance.
6
Kind to Animals
0
Schrödinger's core business is computational chemistry, and there is no evidence of animal-derived products requiring cruelty-free certification.
1
The company's computational platform provides in silico predictions for drug properties, aiming to refine or replace traditional animal testing, indicating that alternative methods are in routine use for internal assessments.
2
Schrödinger supports the FDA's initiative to minimize animal testing in drug development
3
and has a policy requiring suppliers to treat animals used in research humanely and ethically, in compliance with regulations.
4
The company announced a major initiative in 2024, funded by the Bill & Melinda Gates Foundation, to predict toxicology risk early in drug discovery,
5
with a solution expected in the second half of 2025.
6
Schrödinger also enables partners to test compounds digitally, increasing efficiency and reducing waste,
7
and collaborates on developing computational solutions for toxicology risks.
8
The company publicly supports the FDA's plan to reduce animal testing requirements.
9
No War, No Weapons
-40
Schrödinger has a policy to refuse to license software to prospective customers in countries subject to U.S. export restrictions, supported by a Global Export Compliance Policy and mandatory training for employees.
1
The company's Global Human Rights Policy is guided by the UN Universal Declaration of Human Rights and UN Guiding Principles (UNGP) on Business and Human Rights.
2
Schrödinger has a policy to refuse to license software for developing, producing, or using nuclear or biological weapons or missiles.
3
Employees are asked to certify annually that they have read and complied with the Global Code of Business Conduct and Ethics.
4
As of the end of January 2025, Schrödinger recorded completion rates of 99% or higher across all trainings, including Anti-bribery, Anti-corruption, and Anti-money laundering.
5
Planet-Friendly Business
-40
Schrödinger, Inc. aims to set science-based emissions reduction targets aligned with the Science Based Targets initiative by the end of 2025.
1
However, no specific targets have been provided or validated yet.
2
The company reports baseline Scope 1, 2, and 3 greenhouse gas emissions, which are externally assured, but no specific values are disclosed.
3
Three facilities in Framingham, Seoul, and Tokyo achieved LEED green building certifications in 2024, but the percentage of total facilities certified is not specified.
4
Respect for Cultures & Communities
10
Schrödinger has at least 9 formal partnerships with local community groups and academic institutions, including Life Science Cares, University of Texas Southwestern, New York City College of Technology, LaGuardia Community College, LabCentral Ignite’s Career Forge program, Gulf Coast Consortia, Sphoorti Foundation, and Soham Academy of Human Excellence.
1
No cultural appropriation incidents have been reported.
2
The company's Code of Business Conduct and Ethics outlines communication channels for raising concerns, and an Ombuds Office is established in Europe for anonymous reporting.
3
However, these mechanisms are primarily for employees and not explicitly defined as community-specific grievance mechanisms. The company states it sources supplies and other goods and services locally whenever possible, but no specific percentage of procurement spending is provided.
4
Mandatory employee training on maintaining a respectful and harassment-free workplace, anti-bribery/anti-corruption, and human rights topics is implemented, with employees required to acknowledge compliance with the Global Human Rights Policy.
5
As of January 2025, 99% or higher completion rates were recorded across all trainings, but specific cultural sensitivity training completion rates are not provided.
6
Safe & Smart Tech
10
Schrödinger reported zero data breaches, zero law enforcement requests for user information, zero monetary losses from privacy legal proceedings, and zero substantiated customer privacy complaints in 2024.
1
The company's Information Security Department aligns its policies and processes with the NIST Cybersecurity Framework and conducts annual audits.
2
All employees, including part-time and temporary staff, must complete annual security awareness training covering topics like social engineering and phishing, with completion rates of 99% or higher across all ethics and compliance trainings as of January 2025.
3
The company uses TLS certification and fully encrypted transport for security and requires only a single TCP port on the server for its new license manager.
4
Schrödinger states it does not sell personal information and processes opt-out preference signals like Global Privacy Control.
5
Users have rights to access, correct, update, suppress/delete, object to, restrict, or opt out of personal information processing, and can request an electronic copy of their data.
6
The company adheres to local data privacy regulations, including the California Consumer Privacy Act, and has an Ombuds Office in Europe to comply with local laws and the German Supply Chain Due Diligence Act.
7
It collects personal information for purposes such as providing services, ensuring security, and legal compliance, and retains it as long as needed or permitted.
8
The company uses reasonable organizational, technical, and administrative measures to protect personal information.
9
Zero Waste & Sustainable Products
0
The provided articles, including the 2022, 2023, and 2024 Corporate Sustainability Reports, do not contain specific quantitative data for any of the KPIs under the 'Zero Waste & Sustainable Products' ethical value.
1
While general statements about environmental sustainability efforts and intentions to establish science-based greenhouse gas emissions reduction targets are present, there are no metrics on waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability scores, waste audit frequency, zero-waste certifications, waste disposal violations, material efficiency, packaging-to-product ratios, supplier waste requirements, or customer waste education programs.
2